GHP July 2017

GHP / July 2017 23 NEWS , Dr. Wenstrup brings to Oxford Immunotec more than 20 years of clinical leadership experience, including over a decade within the diagnos- tics industry. Most recently, Dr. Wenstrup served as Executive Vice President, Chief Medical Officer, for Myriad Genetics, Inc., where he played a key leadership role and made substantial contri- butions across the company that helped drive and support a mul- ti-fold increase in revenue over a decade. In addition to building and lead- ing Myriad’s clinical and medical affairs teams, Dr. Wenstrup was actively involved in the compa- ny’s product development, M&A, and in-licensing activities. He also previously served as Chief Med- ical Officer for Myriad Genetic Laboratories, Inc. “We are extremely pleased to welcome Rick to the team dur- ing this exciting time at Oxford Immunotec,” said CEO, Dr. Peter Wrighton-Smith. “Rick’s extensive leadership experience and the depth and breadth of his clinical, scientific, and commercial exper- tise will be immensely valuable as we continue to grow our core tuberculosis franchise and launch products into the new markets of tick-borne diseases, blood screening and transplantation.” Prior to joining Myriad Genetics, Dr. Wenstrup served as a tenured Professor of Paediatrics (Human Genetics) at Cincinnati Children’s Hospital Medical Center and as a tenured Professor of Biomed- ical Engineering at the Universi- ty of Cincinnati. During his time in academia, Dr. Wenstrup was principal investigator on multiple research grants from the Nation- al Institutes of Health (NIH) and the FDA Orphan Products Grant Program. He also served as a standing member of NIH review commit- tees and on the scientific advisory boards of several disease-related foundations. Dr. Wenstrup was the founding director of the Mo- lecular Diagnostics Laboratory at Cincinnati Children’s Hospital and co-founder of Assurex Health, Inc., now a subsidiary of Myriad Genetics, Inc. www.oxfordimmunotec.com Figures published by ISD Scot- land for the week ending 2nd July, show that performance was 95.1% - up from 94.5% the previ- ous week. Health Secretary Shona Robi- son said: “I’d like to thank all the health and social care staff who have contributed to the good performance seen in A&E de- partments over this week. Scot- land has had the best performing emergency departments in the UK for more than two years. This has only been possible thanks to the hard work of NHS and social care workers. “We are seeing progress across Scotland and it is encouraging that these latest weekly statis- tics show performance above the four-hour standard. However, we know that the challenge is to en- sure that we maintain this target on a consistent basis, as perfor- mance can fluctuate from week to week. Oxford Immunotec Appoints Chief Medical Officer Scottish A&E Waiting Times Improve Oxford Immunotec Global PLC, a global, high-growth diagnostics company focused on developing and commercialising proprietary tests for the management of underserved immune-regulated conditions, on July 24 announced the appointment of Richard Wenstrup, MD, as Chief Medical Officer. More than 95%of patients inScotland’s core accident and emergency departmentswere seen, admitted or dischargedwithin four hours it has been found. “That is why we are continuing to work closely with boards to take action to minimise long waits and improve patient flow through hos- pitals and into community care. This has been backed by an ad- ditional £9 million of investment to help fund this work and I am con- fident that it will lead to sustained improvements.” The six essential actions for im- proving unscheduled care are: • Clinical focussed and em- powered hospital manage- ment; • Hospital capacity and patient flow realignment; • Patient, rather than bed man- agement; • Medical and surgical pro- cesses arranged to improve patient flow through the un- scheduled care pathway; • Seven day services appropri- ately targeted to reduce var- iation in weekend and out of hours working and; • Ensuring patients are opti- mally cared for in their own homes or a homely setting. www.gov.scot